Mutations of the Epigenetics-Modifying Gene (DNMT3a, TET2, IDH1/2) at Diagnosis May Induce FLT3-ITD at Relapse in De Novo Acute Myeloid Leukemia

Leukemia - United Kingdom
doi 10.1038/leu.2012.317
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

FLT3 Mutations in Childhood Acute Lymphoblastic Leukemia at First Relapse

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Prognostic Significance of WT1 Gene Expression at Diagnosis in Adult De Novo Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1997English

8-Chloro-Adenosine Activity in FLT3-ITD Acute Myeloid Leukemia

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2019English

Landscape of TET2 Mutations in Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

DNA Damage on the DOCK in FLT3-ITD-driven Acute Myeloid Leukemia

Haematologica
Hematology
2019English

Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report From the Children's Oncology Group

Clinical Cancer Research
Cancer ResearchOncology
2015English

Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2015English

Adult Acute Myeloid Leukemia With Trisomy 11 as the Sole Abnormality Is Characterized by the Presence of Five Distinct Gene Mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2016English

Novel Mutations in the FLT3 Gene in Adult Patients With Refractory Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy